KovaDx

New Haven, United States Founded: 2020 • Age: 6 yrs
AI-based tool for red blood cell disease diagnostics is provided.

About KovaDx

KovaDx is a Healthcare company based in New Haven (United States) founded in 2020. It operates as an AI-based tool for red blood cell disease diagnostics is provided. KovaDx has raised $100 thousand across 3 funding rounds from investors including America’s Seed Fund, Village Capital and Expert DOJO. Its chief executive is Yaw Ofosu Ansong. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include PathAI, Viz.ai, Deepcell, Deciphex and Aignostics and 4 more; 9 of its 9 listed competitors have raised funding.

Company details

KovaDx was founded in 2020 in New Haven, United States, within the health technology sector. An AI-driven diagnostic tool is offered to healthcare providers for monitoring patient health and detecting red blood cell diseases. Data is generated through 3D Quantitative Phase Imaging, with AI software processing the results from cellular imaging. Operations focus on enabling accurate diagnostics via this integrated system.

Key Metrics
  • Total Equity Funding
    $100K (USD)

    in 3 rounds

  • Latest Funding Round
    $255.89K (USD), Grant

    Aug 2021

  • Investors

Funding Insights of KovaDx

KovaDx has successfully raised a total of $100K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $255.89 thousand completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $100,000
  • Total Rounds 3
  • Last Round Grant — $255,887
  • Investors Count 3

All 3 funding rounds of KovaDx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2021$255,887Grant––
Jun 2020$100,000Seed––
Jun 2020–Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in KovaDx

KovaDx has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include America’s Seed Fund, Village Capital and Expert DOJO.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital fund backed by the US Government
–seedfund.nsf.govAlexandria, United States
Entrepreneurship support, ecosystem strengthening, and impact investing services are offered by Village Capital.
–vilcap.com-
-
–expertdojo.com-
Premium access

Investor details for KovaDx

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of KovaDx

2 people are tracked at KovaDx (1 in leadership, 1 in team).

NameRoleGroup
Yaw Ofosu Ansong
CEOLeadership
Yaw Ansong
CSOTeam
Premium access

Complete people profiles for KovaDx

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of KovaDx

3 dated milestones of KovaDx across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded KovaDx is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $256K.

Competitors of KovaDx

KovaDx has 9 listed competitors in our database, 9 of them funded. They include PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pathai.com2016Boston, United States$254.94M573
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
viz.ai2016San Francisco, United States$251.99M206
AI and cloud-powered software for stroke care coordination is developed.
deepcell.com2015Mountain View, United States$122.99M94
AI-powered single cell classification and isolation technology for clinical research
deciphex.com2017Dublin, Ireland$56.65M–
Digital pathology software is developed for clinical and veterinary productivity.
aignostics.com2018Berlin, Germany$53.89M25
AI-based pathology diagnostic software is provided for medical analysis.
pictorlabs.ai2019Los Angeles, United States$48.83M–
AI-based tools for pathological image analysis are provided to labs.
paige.ai2018New York, United States$241M–
AI-enabled tools for computational pathology and cancer diagnostics are provided.
nekohealth.com2018Stockholm, Sweden$325.38M–
Platform offering solutions for preventive health scans
proscia.com2014Philadelphia, United States$129.23M85
Provider of an AI and cloud-based digital pathology solution for cancer diagnosis
Premium access

Detailed competitors of KovaDx

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as KovaDx (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about KovaDx

KovaDx was founded in 2020.

KovaDx is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.

Yaw Ofosu Ansong is the current CEO of KovaDx.

KovaDx is a funded company, having raised a total of $100K across 3 funding rounds to date.

KovaDx was founded in 2020 in New Haven, United States, within the health technology sector. An AI-driven diagnostic tool is offered to healthcare providers for monitoring patient health and detecting red blood cell diseases. Data is generated through 3D Quantitative Phase Imaging, with AI software processing the results from cellular imaging. Operations focus on enabling accurate diagnostics via this integrated system.

KovaDx's top competitors include Aignostics, Deciphex and Pictor Labs.

KovaDx has 3 investors. Key investors include America’s Seed Fund, Village Capital, and Expert DOJO.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available